Quarterly report [Sections 13 or 15(d)]

NON CONTROLLING INTEREST (Details)

v3.25.2
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Net loss $ (1,377,276) $ (851,764) $ (1,233,996) $ (1,237,463) $ (2,229,040) $ (2,471,459)
Net loss attributable to the non-controlling interest (143,858)   (16,650)   (154,215) (17,337)
BioCorRx Pharmaceuticals, Inc [Member]            
Net loss $ (594,446)   $ (67,251)   $ (637,230) $ (68,800)
Average Non-controlling interest percentage of profit/losses 24.20%   24.20%   24.20% 24.20%
Net loss attributable to the non-controlling interest $ (143,856)   $ (16,275)   $ (154,210) $ (16,650)
Joseph DeSanto MD [Member]            
Net loss $ (5)   $ (1,072)   $ (15) $ (1,964)
Average Non-controlling interest percentage of profit/losses 35.00%   35.00%   35.00% 35.00%
Net loss attributable to the non-controlling interest $ (2)   $ (375)   $ (5) $ (687)